Rubric Capital Management LP
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 13, 2024), Rubric Capital Management LP reported 66 stock positions worth $3.8 billion. Its top holding was Teva Pharmaceutical-SP ADR (TEVA) at 7.4% of the portfolio, followed by Roivant Sciences (ROIV, 6.4%) and Viatris (VTRS, 5.6%). Compared with Q1 2024, it opened 6 new positions, sold out of 7, added to 31 and reduced 8. The biggest buy was a new position in Jazz Pharmaceuticals (JAZZ) and the biggest sale an exit from iShares Bitcoin Trust ETF (IBIT).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001687509
- Portfolio Value
- $3.8B (Q2 2024)
- SEC Filing
- 0001104659-24-088995 ↗ filed Aug 13, 2024
Holdings Value
Holdings 66 stocks · $3.8B
| TEVA Teva Pharmaceutical-SP ADR | 7.40% | 17,261,741 | $280.5M | Reduce -2.3% |
| ROIV Roivant Sciences Ltd. | 6.41% | 23,000,000 | $243.1M | Add +15.0% |
| VTRS Viatris Inc. | 5.65% | 20,144,365 | $214.1M | Add +9.2% |
| GLNG Golar LNG Ltd. | 5.41% | 6,535,062 | $204.9M | Add +0.4% |
| BGC BGC Group Inc. Class A | 4.16% | 19,000,000 | $157.7M | No change |
| FLR Fluor Corp. | 3.69% | 3,214,521 | $140.0M | Add +23.6% |
| COOP Mr Cooper Group Inc. | 3.26% | 1,518,773 | $123.4M | No change |
| QDEL Quidelortho Corp. | 3.20% | 3,645,590 | $121.1M | Add +51.9% |
| VST Vistra Corp. | 3.01% | 1,327,106 | $114.1M | Add +9.3% |
| LBTYA Liberty Global Ltd. Class A | 2.54% | 5,526,107 | $96.3M | Add +43.7% |
| HRTX Heron Therapeutics Inc. | 2.47% | 26,713,503 | $93.5M | No change |
| ARQT Arcutis Biotherapeutics Inc. | 2.41% | 9,816,672 | $91.3M | Add +30.7% |
| RNW Renew Energy Global PLC-A | 2.22% | 13,506,102 | $84.3M | Add +15.3% |
| COLL Collegium Pharmaceutical Inc. | 1.98% | 2,333,500 | $75.1M | Add +27.2% |
| CAR Avis Budget Group Inc. | 1.90% | 690,273 | $72.1M | Add +220.9% |
| EXTR Extreme Networks Inc. | 1.86% | 5,254,744 | $70.7M | Add +52.3% |
| CSTM Constellium SE | 1.82% | 3,662,895 | $69.0M | Add +0.9% |
| AMRX Amneal Pharmaceuticals Inc. | 1.80% | 10,721,778 | $68.1M | Add +12.4% |
| MATV Mativ Holdings Inc. | 1.79% | 4,000,000 | $67.8M | No change |
| JAZZ Jazz Pharmaceuticals PLC | 1.74% | 616,617 | $65.8M | New |
| PTVE Pactiv Evergreen Inc. | 1.71% | 5,726,583 | $64.8M | Add +3.3% |
| DOLE Dole PLC | 1.66% | 5,141,388 | $62.9M | No change |
| LBTYK Liberty Global Ltd. Class C | 1.65% | 3,511,004 | $62.7M | Add +85.4% |
| ALIT Alight Inc. Class A | 1.64% | 8,423,062 | $62.2M | New |
| MD Pediatrix Medical Group Inc. | 1.62% | 8,150,000 | $61.5M | Add +797.0% |
| SDGR Schrodinger Inc. | 1.60% | 3,130,000 | $60.5M | Add +213.5% |
| OPK Opko Health Inc. | 1.47% | 44,422,304 | $55.5M | Add +800.0% |
| MREO Mereo Biopharma Group PL-ADR | 1.45% | 15,307,347 | $55.1M | Add +12.9% |
| ADEA Adeia Inc. | 1.37% | 4,640,009 | $51.9M | No change |
| ADPT Adaptive Biotechnologies | 1.34% | 14,000,000 | $50.7M | Add +33.3% |
| SSYS Stratasys Ltd. | 1.32% | 5,968,703 | $50.1M | Add +18.2% |
| OFIX Orthofix Medical Inc. | 1.29% | 3,694,946 | $49.0M | Add +0.8% |
| PLAY Dave & Buster's Entertainmen | 1.29% | 1,225,000 | $48.8M | Add +104.7% |
| TDOC Teladoc Health Inc. | 1.19% | 4,628,532 | $45.3M | New |
| KNSA Kiniksa Pharmaceuticals Inte | 1.19% | 2,419,103 | $45.2M | Add +10.2% |
| VYX NCR Voyix Corp. | 1.12% | 3,437,030 | $42.4M | Reduce -24.4% |
| AIR Aar Corp. | 1.10% | 575,000 | $41.8M | Reduce -20.7% |
| ANIP Ani Pharmaceuticals Inc. | 1.01% | 603,800 | $38.4M | Reduce -37.0% |
| XPER Xperi Inc. | 0.90% | 4,143,744 | $34.0M | Add +2.5% |
| ZYME Zymeworks Inc. | 0.88% | 3,917,331 | $33.3M | Add +12.7% |
| TAC Transalta Corp. | 0.88% | 4,687,158 | $33.2M | No change |
| GDRX Goodrx Holdings Inc. Class A | 0.77% | 3,736,802 | $29.1M | Add +76.5% |
| FIP Ftai Infrastructure Inc. | 0.73% | 3,193,530 | $27.6M | No change |
| RSKD Riskified Ltd. Class A | 0.70% | 4,173,636 | $26.7M | No change |
| CNNE Cannae Holdings Inc. | 0.68% | 1,430,248 | $25.9M | Add +17.8% |
| CHRS Coherus Oncology Inc. | 0.47% | 10,400,000 | $18.0M | No change |
| SCPH Scpharmaceuticals Inc. | 0.40% | 3,525,000 | $15.3M | No change |
| CRS Carpenter Technology | 0.40% | 139,806 | $15.3M | Add +77.7% |
| TRVI Trevi Therapeutics Inc. | 0.40% | 5,026,931 | $15.0M | Reduce -9.7% |
| SSTK Shutterstock Inc. | 0.39% | 381,631 | $14.8M | New |
| ARDX Ardelyx Inc. | 0.36% | 1,816,585 | $13.5M | No change |
| KOP Koppers Holdings Inc. | 0.35% | 361,487 | $13.4M | Reduce -36.9% |
| OABI Omniab Inc. | 0.28% | 2,850,588 | $10.7M | No change |
| TSAT Telesat Corp. | 0.23% | 959,764 | $8.7M | No change |
| PLYA Playa Hotels & Resorts NV | 0.23% | 1,037,788 | $8.7M | Reduce -75.0% |
| PTGX Protagonist Therapeutics Inc. | 0.18% | 198,059 | $6.9M | No change |
| RVNC Revance Therapeutics Inc. | 0.18% | 2,656,847 | $6.8M | No change |
| MYPS Playstudios Inc. | 0.15% | 2,711,190 | $5.6M | Add +14.5% |
| SPRY Ars Pharmaceuticals Inc. | 0.14% | 639,203 | $5.4M | No change |
| ABUS Arbutus Biopharma Corp. | 0.14% | 1,681,090 | $5.2M | New |
| BCYC Bicycle Therapeutics PLC-ADR | 0.11% | 205,423 | $4.2M | No change |
| OVID Ovid Therapeutics Inc. | 0.11% | 5,315,969 | $4.1M | No change |
| HOWL Werewolf Therapeutics Inc. | 0.09% | 1,333,893 | $3.3M | Reduce -17.7% |
| TXMD Therapeuticsmd Inc. | 0.05% | 1,192,191 | $1.9M | No change |
| IMVT Immunovant Inc. | 0.04% | 58,624 | $1.5M | New |
| VINCERX PHARMA INC | 0.00% | 116,873 | $95K | No change |
Options reported separately and not counted above: GLNG calls ($21.9M).
Other holdings (1): bonds, preferreds, convertibles and warrants · $1.8M (not counted above)
| Security | Class | Shares / Principal | Value | Change |
|---|---|---|---|---|
| COHERUS ONCOLOGY INC (CHRS 1.5 04/15/26) | NOTE 1.500% 4/1 · principal | 2,500,000 | $1.8M | No change |
Total filed on the 13F, all lines: $3.8B.
Portfolio Sells Q1 2024 → Q2 2024
| IBIT iShares Bitcoin Trust ETF | Sold out | 0.00% | −2.06 |
| ATMU Atmus Filtration Technologie | Sold out | 0.00% | −1.08 |
| PLYA Playa Hotels & Resorts NV | Reduce -75.0% | 0.23% | −0.96 |
| ANIP Ani Pharmaceuticals Inc. | Reduce -37.0% | 1.01% | −0.94 |
| PARR Par Pacific Holdings Inc. | Sold out | 0.00% | −0.85 |
| SWTX Springworks Therapeutics Inc. | Sold out | 0.00% | −0.62 |
| NUVL Nuvalent Inc. Class A | Sold out | 0.00% | −0.58 |
| KOP Koppers Holdings Inc. | Reduce -36.9% | 0.35% | −0.58 |
| VYX NCR Voyix Corp. | Reduce -24.4% | 1.12% | −0.58 |
| CGEM Cullinan Therapeutics Inc. | Sold out | 0.00% | −0.32 |
| HOWL Werewolf Therapeutics Inc. | Reduce -17.7% | 0.09% | −0.22 |
| AIR Aar Corp. | Reduce -20.7% | 1.10% | −0.18 |
| TRVI Trevi Therapeutics Inc. | Reduce -9.7% | 0.40% | −0.17 |
| XERS Xeris Biopharma Holdings Inc. | Sold out | 0.00% | −0.02 |
| TEVA Teva Pharmaceutical-SP ADR | Reduce -2.3% | 7.40% | +0.03 |
Portfolio Buys Q1 2024 → Q2 2024
| JAZZ Jazz Pharmaceuticals PLC | New | 1.74% | +1.74 |
| ALIT Alight Inc. Class A | New | 1.64% | +1.64 |
| MD Pediatrix Medical Group Inc. | Add +797.0% | 1.62% | +1.35 |
| OPK Opko Health Inc. | Add +800.0% | 1.47% | +1.29 |
| TDOC Teladoc Health Inc. | New | 1.19% | +1.19 |
| CAR Avis Budget Group Inc. | Add +220.9% | 1.90% | +1.12 |
| SDGR Schrodinger Inc. | Add +213.5% | 1.60% | +0.80 |
| GLNG Golar LNG Ltd. | Add +0.4% | 5.41% | +0.78 |
| EXTR Extreme Networks Inc. | Add +52.3% | 1.86% | +0.69 |
| LBTYK Liberty Global Ltd. Class C | Add +85.4% | 1.65% | +0.67 |
| LBTYA Liberty Global Ltd. Class A | Add +43.7% | 2.54% | +0.62 |
| VST Vistra Corp. | Add +9.3% | 3.01% | +0.51 |
| FLR Fluor Corp. | Add +23.6% | 3.69% | +0.44 |
| SSTK Shutterstock Inc. | New | 0.39% | +0.39 |
| ADPT Adaptive Biotechnologies | Add +33.3% | 1.34% | +0.34 |
| GDRX Goodrx Holdings Inc. Class A | Add +76.5% | 0.77% | +0.32 |
| CRS Carpenter Technology | Add +77.7% | 0.40% | +0.24 |
| ARQT Arcutis Biotherapeutics Inc. | Add +30.7% | 2.41% | +0.21 |
| ROIV Roivant Sciences Ltd. | Add +15.0% | 6.41% | +0.18 |
| PLAY Dave & Buster's Entertainmen | Add +104.7% | 1.29% | +0.18 |
| RNW Renew Energy Global PLC-A | Add +15.3% | 2.22% | +0.15 |
| ABUS Arbutus Biopharma Corp. | New | 0.14% | +0.14 |
| MREO Mereo Biopharma Group PL-ADR | Add +12.9% | 1.45% | +0.13 |
| AMRX Amneal Pharmaceuticals Inc. | Add +12.4% | 1.80% | +0.09 |
| IMVT Immunovant Inc. | New | 0.04% | +0.04 |
| MYPS Playstudios Inc. | Add +14.5% | 0.15% | −0.05 |
| KNSA Kiniksa Pharmaceuticals Inte | Add +10.2% | 1.19% | −0.09 |
| CNNE Cannae Holdings Inc. | Add +17.8% | 0.68% | −0.11 |
| COLL Collegium Pharmaceutical Inc. | Add +27.2% | 1.98% | −0.12 |
| ZYME Zymeworks Inc. | Add +12.7% | 0.88% | −0.20 |
| QDEL Quidelortho Corp. | Add +51.9% | 3.20% | −0.21 |
| OFIX Orthofix Medical Inc. | Add +0.8% | 1.29% | −0.28 |
| SSYS Stratasys Ltd. | Add +18.2% | 1.32% | −0.41 |
| XPER Xperi Inc. | Add +2.5% | 0.90% | −0.54 |
| CSTM Constellium SE | Add +0.9% | 1.82% | −0.55 |
| PTVE Pactiv Evergreen Inc. | Add +3.3% | 1.71% | −0.64 |
| VTRS Viatris Inc. | Add +9.2% | 5.65% | −0.86 |
Options Activity Q1 2024 → Q2 2024
| GLNG Golar LNG Ltd. | call | New | 700,000 | $21.9M |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 86 | $10.9B | TLN, FTAI, VTRS, TEVA, GLNG |
| Q1 2026 | 81 | $8.2B | TLN, FTAI, GLNG, TEVA, VTRS |
| Q4 2025 | 75 | $8.4B | TLN, FTAI, TEVA, GLNG, VST |
| Q3 2025 | 69 | $7.4B | TLN, FTAI, TEVA, GLNG, ROIV |
| Q2 2025 | 62 | $6.2B | TLN, TEVA, FTAI, GLNG, VST |
| Q1 2025 | 64 | $5.6B | TLN, TEVA, GLNG, FTAI, QDEL |
| Q4 2024 | 66 | $5.5B | TLN, TEVA, GLNG, VTRS, QDEL |
| Q3 2024 | 62 | $6.1B | TLN, TEVA, ROIV, VST, GLNG |
| Q2 2024 | 66 | $3.8B | TEVA, ROIV, VTRS, GLNG, BGC |
| Q1 2024 | 67 | $3.4B | TEVA, VTRS, ROIV, GLNG, BGC |